SEARCH

SEARCH BY CITATION

REFERENCES

  • Allegaert K, Lewi L, Naulaers G, Lagae L. (2006) Levetiractam pharmacokinetics in neonates at birth. Epilepsia 47:10681069.
  • Anderson GD. (2005) Pregnancy-induced changes in pharmacokinetics. A mechanistic-based approach. Clinical Pharmacokinetics 44:9891008.
  • Blackburn ST. (1994) Renal function in the neonate. Journal of Perinatal and Neonatal Nursing 8:3747.
  • French JA, Kanner AM, Bautista J Abou-Khalil B, Browne T, Harden CL, Theodore WH, Bazil C, Stern J, Schachter SC, Bergen D, Hirtz D, Montouris GD, Nespeca M, Gidal B, Marks WJ Jr, Turk WR, Fischer JH, Bourgeois B, Wilner A, Faught RE Jr, Sachdeo RC, Beydoun A, Glauser TA. (2004) Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62:12611273.
  • Grunewald R. (2005) Levetiracetam in the treatment of idiopathic generalized epilepsies. Epilepsia 46(suppl 9):154160.
  • Johannessen SI, Helde G, Brodtkorb E. (2005) Levetiracetam concentrations in serum and in breast milk at birth and lactation. Epilepsia 46:775777.
  • Krämer G, Hösli I, Glanzmann R (2002) Levetiractem accumulation in human breast milk. Epilepsia 43(suppl 7):105.
  • Long L. (2003) Levetiracetam monotherapy during pregnancy: a case series. Epilepsy and Behaviour 4:447448.
  • Mazzucchelli I, Onat FY, Ozkara C, Atakli P, Specchio LM, La Neve A, Gatti G, Perucca E. (2006) Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium. Epilepsia 47:504509.
  • Patsalos PN. (2004) Clinical pharmacokinetics of levetiracetam. Clinical Pharmacokinetics 43:707724
  • Pennell PB, Koganti A, Helmers S, Beach A, Newman M, Newport DJ, Stowe ZN. (2005) The impact of pregnancy and childbirth on the elimination of levetiracetam. Epilepsia 46(suppl 8):89.
  • Perucca E, Johannessen SI. (2003) The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come? Epileptic Disorders 5(suppl 1):S17S26.
  • Ten Berg K, Samrén BE, Van Oppen AC, Engelsman M, Lindhout D. (2005) Levetiracetam use and pregnancy outcome. Reproductive Toxicology 20:175178.
  • Tomson T. (2005) Gender aspects of pharmacokinetics of new and old AEDs: Pregnancy and breast-feeding. Therapeutic Drug Monitoring 27:718721.